Drugs in clinical trial

FDA PHASE NAME: AAB-001 OTHER NAMES: Bapineuzumab, Humanized monoclonal anti-Aβ antibody FDA PHASE: Phase III

NAME: ACC-001 FDA PHASE: Phase I

NAME: Acetyl-l-carnitine HCI OTHER NAMES: ALCAR FDA PHASE: Discontinued

NAME: AF 102B OTHER NAMES: cevimeline HCL, Evoxac™ FDA PHASE: Discontinued

NAME: Alpha-tocopherol OTHER NAMES: Vitamin E

NAME: Alzhemed™ OTHER NAMES: 3-amino-1-propanesulfonic acid, 3-aminopropylsulfonic acid, 3-APS, homotaurine, NC-531, Tramiprosate FDA PHASE: Phase III

NAME: AN 1792 OTHER NAMES: AIP 001 FDA PHASE: Discontinued

NAME: Atorvastatin OTHER NAMES: Lipitor™ FDA PHASE: Phase II/IIa/IIb

NAME: AZD3480 OTHER NAMES: ispronicline, TC-1734 FDA PHASE: Phase II/IIa/IIb

NAME: Besipirdine HCl OTHER NAMES: HP 749 FDA PHASE: Discontinued

NAME: Beta- & Gamma-Secretase Inhibitors FDA PHASE: Preclinical

NAME: Cerebrolysin FDA PHASE: Approved outside U.S.

NAME: Clioquinol OTHER NAMES: iodochlorhydroxyquin, PBT-1 FDA PHASE: Discontinued

NAME: COGNIShunt™ FDA PHASE: Phase II/IIa/IIb

NAME: CX516 OTHER NAMES: Ampalex FDA PHASE: Phase II/IIa/IIb

NAME: Dapsone OTHER NAMES: Avlosulfon FDA PHASE: Phase II/IIa/IIb

NAME: Dimebon OTHER NAMES: 3,6-dimethyl-9-(2-methyl-pyridyl-5)-ethyl-1,2,3,4-tetrahydro-γ-carboline dihydrochloride FDA PHASE: Phase II/IIa/IIb

NAME: Docosahexanoic acid (DHA) OTHER NAMES: Omega 3 fatty acids FDA PHASE: Phase III

NAME: Donepezil OTHER NAMES: Aricepts™ FDA PHASE: FDA approved MECHANISMS: cholinesterase inhibitors ROLE IN ALZHEIMER'S DISEASE: Improves cognition, global function, and activities of daily living.